Aarti Industries Limited Aarti Industries Limited is a manufacturer of specialty chemicals and pharmaceuticals. Aarti started its operations in1975 as alchemie labs. The company also manufactures home and personal care products. It operates through three segments: speciality chemicals, pharmaceuticals and home and personal care chemicals. Aarti is one of the leading suppliers to global manufacturers of dyes, pigments, agrochemicals, pharmaceuticals and rubber chemicals and has acquired world-class expertise in the field. It is amongst the largest producers of benzene based basic and intermediate chemicals in India. It has corporate office in Mumbai and representatives in U.S.A and Europe. The company is integrated across over 70 products.
Abbott India Limited Abbott, incorporated in 1910, is engaged in the discovery, development, manufacture and sale of a line of healthcare products. Abbott has a diverse range of science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and vision, diabetes and vascular devices.
Headquartered in Mumbai, Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories, takes pride in offering high-quality trusted medicines in multiple therapeutic categories such as women’s health, gastroenterology, cardiology, metabolic disorders and primary care.
Abbott India Limited is part of Abbott’s global pharmaceutical business in India and one of the fastest-growing pharmaceutical companies. Abbott India Limited believes in providing quality healthcare through a mix of global and local products for people in India.
Advanced Enzyme Technologies Limited Advanced Enzyme Technologies Limited manufactures and sales enzymes for India and abroad. It provides solutions to industries, such as human healthcare and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing and malting, grain processing, protein modification, dairy processing, natural extraction, textile processing, leather processing, paper and pulp processing, biofuels, biomass processing and biocatalysts. Company aims to replace traditionally used chemicals with eco-friendly enzymatic solutions. It has pioneered in the production of enzymes in India and continues to set trends with the research & development of new applications for the use of enzymes across various industries. Equipped with state-of-the-art manufacturing facilities and research and development centers across India and US, the company offers several 100 enzyme products.
Ajanta Pharma Limited Ajanta Pharma Limited is a holding company. It is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations. Its business includes branded generics in emerging markets such as Asia and Africa and developed markets such as the United States and institutional sales.
The branded generics business is spread in India and over 30 emerging countries across Africa, commonwealth of independent states (CIS), the Middle East and South East Asia. The company serves a range of therapeutic segments, such as anti-biotic, anti-malarial, anti- diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory and general health products. It has approximately four existing manufacturing plants located in and around Aurangabad in Maharashtra.
Alembic Pharmaceuticals Limited Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and intermediates.
It is engaged developing formulations and active pharmaceutical ingredients (API). The company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The company offers international and domestic formulations.
Alkem Laboratories Limited Alkem Laboratories Limited is a pharmaceutical company established in 1973. The company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The company operates through two segments: pharmaceutical and investing. It produces generics, generic drugs, active pharmaceutical ingredients (APIs) and neutraceuticals, which it markets in India and approximately 50 countries internationally, primarily the United States. It is currently ranked the fifth largest pharmaceutical company in India in terms of domestic sales for the fiscal year 2016 with its iconic brands like Clavam, Pan, Pan-D, Taxim and Taxim-O featuring amongst the top 50 pharmaceutical brands in India. The company has approximately 16 manufacturing facilities, of which 14 manufacturing facilities are at geographically diversified locations in India and two in the United States. The company is listed on BSE and NSE.
AstraZeneca Pharma India Limited AstraZeneca Pharma India Limited is a global biopharmaceutical company. It was established in 1979 and is headquartered at Bengaluru. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular and metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. It operates through two segments: healthcare and clinical trial.
The healthcare segment engages in the manufacture and sale of pharmaceutical products. The clinical trial segment renders services on pharmaceutical products to its group companies. It has presence in over seven areas of healthcare, including diabetes, oncology, infection, local anesthesia and maternal healthcare. The principal products/services of the company are Meronem and Brilinta/Axcer.
Astec LifeSciences Limited Astec LifeSciences Limited is an India- based holding company incorporated in 1994. The company is engaged in agro chemicals, including fungicides and herbicides business. It manufactures a range of agrochemical active ingredients and pharmaceutical intermediates.
Astec manufactures a wide range of agrochemical active ingredients and pharmaceutical intermediates. Astec’s considerable experience in the development and production of intermediates and active ingredients makes it an ideal partner. Astec has stable relationships with large and small companies all over the world. Astec has an unshakeable reputation for providing quality products in manufacturing plants that meet global standards. In addition, the company has undertaken a number of custom synthesis projects for customers in Europe, Japan and the United States.
Arvind Remedies Limited Arvind Remedies Limited is an India-based company engaged in manufacturing pharmaceutical products. It is focusing on chronic diseases segments like diabetics, arthiritis and obesity.
The company has presence in both retail, as well as institutional segments. It sells its products India and other countries. The company’s subsidiaries include Arvind Wellness Limited, Arvind Remedies Inc. and Arvind Remedies USA LLC.
Aurobindo Pharma Limited Aurobindo Pharma Limited is a pharmaceutical company thatproduces oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, antiretrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It also develops inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.
Biocon Limited Biocon Limited is a biopharmaceutical company that focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The company has developed and taken a range of novel biologics, biosimilars, differentiated small molecules and affordable recombinant human Insulin and analogs from lab to market.
The company’s brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti- CD6 monoclonal antibody. It has a pipeline of biosimilars and novel biologics at various stages of development, including insulin tregopil, an oral insulin analog.
Cadila Pharmaceuticals Ltd Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad. Over the last six decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over eighty-five other countries around the world.
The company is present in more than forty-five therapeutic areas focusing strongly on innovation and research, spread across twelve specialities, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals.
Cadila Pharmaceuticals Excellence in manufacturing facilities is central to Cadila Pharmaceuticals. The company’s formulations manufacturing plant at Dholka near Ahmedabad, is spread over hundred acres of land. This state-of-the- art facility is not only impressive in size, but is also USFDA approved.
Caplin Point Laboratories Limited Caplin Point Laboratories Limited is a pharmaceutical company. The company’s product segments include antibiotics, non-steroidal anti-inflammatory drugs (NSAIDS), ophthalmics, pain management and antiulcers.
It offers a range of products, including tablets, liquid orals, capsule, softgel capsules, suppositories and ovules, powder for injection, dry syrup, topicals, liquid injections, inhalers, intravenous (IV) infusion, lyophilized products, branded products, dermo cosmetics and other products. It also manufactures a range of ointments, creams, gels and lotions. Caplin Point has made a foray into the regulated markets with its latest manufacturing facility that is already approved by EU-GMP and ANVISA-Brazil. The facility is awaiting the coveted US FDA approval for injectables in the near future.
Cipla Limited Cipla Limited is a global pharmaceutical company incorporated in 1935. The company’s strategic business units include active pharmaceutical ingredients (APIs), respiratory and Cipla Global Access. Its geographical segments include India, USA, South Africa and rest of the world. The company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices.
Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The company offers its products for the therapeutic areas, including cardiovascular, children’s health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women’s health.
Claris LifeSciences Limited Claris LifeSciences Limited is a holding company. The company manufactures drugs and pharmaceutical products for India and abroad. Its subsidiary, Claris Injectables Limited, is engaged in specialty injectables business. The company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective’s, critical care, and nephrology. The company, through Claris Otsuka Private Limited, is engaged in infusion products business across therapeutic segments, including infusion therapy, parenteral nutrition and plasma volume expanders. Its products are offered through various delivery systems, such as glass and plastic bottles, ampoules and bags. It provides its services to government and semi-government institutions, group corporate hospitals and nursing homes.
Dishman Pharmaceuticals and Chemicals Limited Dishman Pharmaceuticals and Chemicals Limited operates as an outsourcing partner for the pharmaceutical industry. The company manufactures and supplies intermediates, fine chemicals and various products for pharmaceutical, cosmetic and related industries. Its segments include contract research and contract manufacturing (CRAMS), and bulk drugs, intermediates, quats, specialty chemicals and traded goods. The company’s CRAMS business segment caters to the requirements of multinational pharmaceutical companies across the world. Its product portfolio includes active pharmaceutical ingredients (APIs), high potent APIs, intermediates, phase transfer catalysts, Vitamin D, Vitamin D analogues, cholesterol, lanolin-related products, and antiseptic and disinfectant formulations. Its products are used in various applications, such as phase transfer catalysts, fine chemicals and disinfectants. Its business units include generic API, dishman specialty chemicals, and dishman care.
Dr. Reddy’s Laboratories Limited Dr. Reddy’s Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The company was founded by scientist, philanthropist and entrepreneur, Dr. K Anji Reddy. The company operates in three segments: global generics, pharmaceutical services and active ingredients (PSAI), and proprietary products.
The global generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company’s business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited is engaged in providing diagnostic and related healthcare tests and services. The company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, and cytology, other pathological and radiological investigations.
The company’s geographical segments include India and abroad. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of liver, disorders of bone, drugs of abuse, infertility, lymphoma, water purity, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, pregnancy and viral infections. The company’s other offerings include diabetes care program, loyalty card and wellness card.
Divi’s Laboratories Limited Divi’s Laboratories Limited established in1990 manufactures and sale of active pharmaceutical ingredients (APIs) and intermediates. The company’s geographical segments include India (sales to customers within India) and other countries (sales to customers outside India). Its products include generic APIs, intermediates, peptide building blocks and carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life cycle and generic drug manufacturers.
The company develops carotenoids, such as apocarotenal, betacarotene, lycopene, astaxanthin and canthaxanthin. It manufactures tert-butoxycarbonyl (BOC), Fluorenylmethyloxycarbonyl (FMOC) and Carboxybenzyl (CBZ) protected amino acids. It manufactures ligands, such as binol and binap. The Company exports its products to European and the American countries. Its manufacturing and research and development facilities are located in Andhra Pradesh and Telangana in India.
Elder Pharmaceuticals Limited Elder Pharmaceuticals Limited manufactures and markets prescription pharmaceutical brands, surgical and medical devices. The company operates through Pharmaceuticals segment. It has operations in therapeutic segments, such as women’s health, wound care, pain management, anti-infective, nutraceuticals and lifestyle disease care. The company’s products under active pharmaceutical ingredients (API) list include Diosmin, Diacerein and Tolfenamic Acid. Its formulation products include products for hormones, calcium supplements, dietary products, anti-hemorrhoidal products and wound care products. It also offers hair care products, such as hair conditioner and hair cream; skin care products, such as facial scrub, face wash; soaps, such as acne soap and moisturizing soap, and ayurvedic products, such as Paynx balm.
Eli Lilly and Company Ltd Eli Lilly and Company Ltd was incorporated by Colonel Eli Lilly in 1876. It is the 10th largest pharmaceutical company in the world at present. Lilly has remained committed to creating medicines that help improve peoples’ quality of life.
Eli Lilly & Company has discovered, developed and acquired innovative new medicines that address key unmet medical needs worldwide for more than 140 years. Across the globe, company also has strong alliances and partnerships that advance its capacity to develop innovative medicines at lower costs.
Eli Lilly and Company India Pvt. Ltd. is the wholly-owned Indian subsidiary of Eli Lilly and Company. Since its inception in India, in 1993, Lilly has been committed to developing and marketing pharmaceutical products to treat diabetes, cancer, osteoporosis and growth-hormone deficiency.
Fresenius Kabi Oncology Limited Fresenius Kabi Oncology Limited is a public company operating in the field of research and development and manufacturing of world-class oncology drugs. The company strives to provide state-of-the-art third generation chemotherapeutic drugs right from development to manufacturing and marketing across the globe. It is fast budding as a leading player in oncology generics on the strength of its comprehensive product portfolio of injectables, oral cytotoxics, cytostatics, intermediates and active pharmaceutical ingredients (APIs).
The company develops, manufactures and markets anti-cancer products for critically and chronically ill patients. As a part of the globally reputed Fresenius Healthcare Group, it plays a pivotal role in patient care, both within and outside hospitals. The company has been able to leverage the global outreach in benchmarking oncology excellence with latest world class production, ultramodern manufacturing and research and development facilities.
FDC Limited FDC Limited is a pharmaceutical company that manufactures specialized formulations, and oral rehydration salts (ORS). Its therapeutic areas of focus include anti-infectives, gastrointestinals, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology and analgesics. FDC carries forward the flaming spirit of its first dream, achieving accreditations from the US-FDA, UK-MHRA, MCC-RSA, and the UAE, to cite a few. FDC has also set-up globally approved, multi-location manufacturing facilities for active pharmaceuticals ingredients (APIs) as well as finished dosage forms. It has multi-location manufacturing facilities for APIs, as well as finished dosage forms. Its facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh
GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The company’s product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas, and it also offers a range of vaccines for prevention of life-threatening diseases, such as pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, small pox and influenza. It provides healthcare solutions to patients, with a range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The company’s manufacturing unit is located at Nashik, and its clinical development center is located in Bangalore. GSK has ranked as the No.1 Most Reputed Pharmaceutical brand amongst MNC’s in India.
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited is a global pharmaceutical company established in 1977 by Emeritus Late Mr. Gracias Saldanha. The company develops new chemical entities (NCEs) and new biological entities (NBEs). It supplies are India, United States, Latin America, Europe and rest of the world.
It has approximately seven molecules, over two NCEs and approximately five NBEs in various stages of pre-clinical and clinical development. It is focused on developing and marketing branded and generic formulations. It focuses on manufacturing products across therapeutic areas of dermatology, respiratory and oncology. Its active pharmaceuticals ingredients (API) business spans over 80 countries, including regulated markets of the United States, Europe, Japan and Canada. Its products are primarily marketed in the United States and western Europe. It has offices in over 40 countries, and operates approximately 20 manufacturing facilities in over five countries. It operates over five research and development (R&D) centers.
Granules India Limited Granules India Limited is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The company’s business operations include three areas: core business, emerging business, and contract research and manufacturing services (CRAMS). Its products in core business include Paracetamol, Ibuprofen, Guaifenesin and Metformin. The company operates a healthcare division, Granules Consumer Healthcare (GCH). The company, through an acquisition, has access to over 10 APIs, as well as intermediates in therapeutic categories, such as anti-histaminic, antihypertensive and anti-convulsants.
Haffkine Bio-Pharmaceutical Corporation Ltd Haffkine Institute was found- ed by Dr. Waldemar Mordecai Haffkine on 10th Janu- ary 1899. It is located in Parel in Mumbai. In 1975, it was divided into Haffkine BioPharmaceutical Corporation Ltd and Haffkine Institute of Training, Research and testing, focused on vaccine production and research. Recently, it has been short-listed by the Maharashtra government as the future institution for providing clinical trial training to doctors, pharmacologists and scientists across India.
Haffkine BioPharmaceutical Corporation Ltd developed first indigenous oral polio vaccine (OPV). Owing to strategic planning and sustained efforts, the company has been increasing its profits since 1997-98. It had employee strength of about 600 in 2001-02. Its R&D laboratory in Pimpri has been producing antitoxins and sera for scorpion and snake venom, diphtheria and tetanus toxins. It has a well-equipped animal-breeding lab in Mumbai.
Hikal Limited Hikal Limited is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharmaceutical ingredients (APIs) and contract research activities. Established in 1988, Hikal is a reliable partner to companies in the pharmaceuticals, biotech, agrochemicals and Specialty Chemicals industries. The company’s advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. The company offers pharmaceuticals and agrochemicals. Its segments include crop protection and pharmaceuticals. The company operates in geographical areas, including India, Europe, the United States, Canada and South East Asia.
Indoco Remedies Limited Indoco Remedies Limited is an Indiabased company, which is engaged in the manufacture of pharmaceutical products. The company primarily manufactures and markets formulations (Finished Dosage Forms) and active pharmaceutical ingredients (APIs).
The company’s geographical segments include India andabroad It offers products for various therapeutic categories, such as stomatologicals, respiratory, anti-infectives, gastrointestinal, pain/analgesics, gynecological, vitamins/minerals/nutrients, ophthal/otologicals and dermatology. Its domestic marketing divisions include INDOCO, SPADE, Warren NxGen, Warren Ace, Spera, Indoco Focus, Indoco CND, Warren Excel, Warren Vision, Eterna, Institution and Indoco IMPULSE. As of today, the company operates in over 35 countries globally for Formulations and APIs. With approval of its Finished Dosage facilities by the US – FDA, Darmstadt – Germany, TGA Australia, MCC-South Africa and UK – MHRA, Indoco has emerged as the most suitable partner and provider of Contract Research and Manufacturing Services (CRAMS) to its customers globally.
Kopran Limited Kopran Limited’s business units include finished dosage forms, active pharmaceutical ingredients, research and D\development, and consumer healthcare. It offers its products in therapeutic categories, such as anthelmintic, anti-allergic, antibiotic, cardiovascular, diabetic, gastroenterology, pain and antipyretic, and pain management, among others. In addition, it offers oral care, lifestyle, beauty and personalized hygiene products. Its manufacturing facility is located at Khopoli, Maharashtra. The company’s subsidiaries include Kopran Research Laboratories Limited, Kopran (H.K) Limited and Kopran Lifesciences Limited. Kopran’s products are registered globally and its facilities match best of international standards and are approved by various regulatory authorities. It is focused on improvement in technology and new products duly integrated through their sophisticated R&D development
Lupin Limited Lupin Limited produces, develops and markets a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The company offers products in the cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives and non-steroidal antiinflammatory drug therapy areas. It also offers solutions in the anti-tuberculosis (anti-TB) and cephalosporins therapy areas. The company along with its subsidiaries has manufacturing locations spread across India, Japan, the United States, Mexico and Brazil.
It was named after the Lupin flower because of the inherent qualities of the flower and what it personifies and stands for. Forty six years on, what has stayed with Lupin is that same entrepreneurial spirit, culture of creativity and innovation and pride in belonging to an industry that makes a difference in the lives of people.
Mankind Pharma Mankind Pharma was incorporated in 1986. In 1991,it was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. The company provides a wide range of products – antibiotic, antifungal, NSAIDs, gastrointestinal, anthelmintic, cardiovascular, dermal, erectile dysfunction, and several other categories – across the nation.
In 2007, Mankind acquired Magnet Labs Pvt Ltd, establishing a marketing presence in the antipsychotic segment. Later in January 2010, the company acquired the former brand of UCB Belgium, Longifene.
Mankind Pharma takes great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, PregaNews, Adiction, Gas-O-Fast, Kaloree 1, and our latest launch, Heal-OKind.
Marksans Pharma Limited Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company’s product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central nervous system, Antibiotic, Gastrointestinal, Anti-allergic and Miscellaneous.The Company undertakes research and development initiatives, and offers customer relationship management (CRM) services to global pharmaceutical companies. The Company has a manufacturing facility for the manufacture of oral solid tablets and soft gelatin capsules in Goa; a liquids/ointments/sachets manufacturing facility in Southport, the United Kingdom, and a solid oral dosages manufacturing facility in New York, the United States. It supplies products to approximately 20 countries. Its subsidiaries include Nova Pharmaceuticals Australasia Pty Ltd. and Marksans Pharma (UK) Limited.
Merck Limited Merck Limited is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. Merck Limited (formerly E. Merck Limited) was set up in India as Merck’s first Asian subsidiary in 1967. It was also the first Merck Group Company to go public in 1981. The company operates through two segments: pharmaceuticals and chemicals. Its geographical segments include domestic and exports.
Merck’s state-of-the-art Galenic and Analytical Development Laboratory in Navi Mumbai enables it to react faster to market demands, have better quality control and ensure world-class formulations by developing in-house various galenic forms like tablets, capsules, injections, syrups, dry powders, creams, etc.
Morepen Laboratories Limited Morepen Laboratories Limited is a pharmaceutical company. The company’s divisions include active pharmaceutical ingredients (API), home diagnostics and finished formulations.
The company offers products under the self-health diagnostic brand home health. Its home health portfolio includes automatic digital blood pressure monitors, digital and analog weighing scales, body and foot massagers, heat therapy range, nebulizers, pregnancy cards, and clinical and digital thermometers. It markets various brands of medical devices and clinical diagnostic products. The company operates in India, the United States and rest of world.
Morepen’s state-of-art manufacturing facility in the picturesque environs of Baddi comprises a scientifically integrated complex of 10 plants, each with a specific product profile. The company’s extensive R&D facilities and factories are manned by a dedicated team of professionals who ensure stringent quality standards.
Micro Labs Limited Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. Energetically backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations.
Micro’s brand portfolio includes some of the topmost brands in various specialties like cardiology, diabetology, anti-infectives, ophthalmology, pain, etc. Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management. The company is also at the front position in social contribution, striving to be a model corporate citizen in terms of environmental protection and social initiatives with significant contributions in the areas of education and health.
Natco Pharma Limited Natco Pharma Limited is a pharmaceutical company incorporated in Hyderabad in 1981 with an initial investment of Rs 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has five manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.
The company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company’s segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. Its product categories include Domestic Formulations, International Formulations, API’s and Blockbusters. The company manufactures over 20 products under contract.
Novartis Novartis AG, incorporated on March 1, 1996, is a holding company. The Company specializes in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals, including eye care products.
Its portfolio includes medicines, eye care and generic pharmaceuticals. The Company’s segments include Pharmaceuticals which researches, develops, manufactures, distributes and sells prescription medicines in the therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience and established medicines.
The history of Novartis traces the converging destinies of three companies: Geigy, a chemicals and dyes trading company founded in Basel, Switzerland in the middle of the 18th century; Ciba, which began producing dyes in 1859; and Sandoz, a chemical company founded in Basel in 1886.
Nicholas Piramal India Limited The Piramal Group acquired shareholding of F.Hoffmann-La Roche Ltd., Switzerland, in the Indian subsidiary, Roche Products Limited. Post acquisition, the company was renamed as Piramal Healthcare Ltd.
Piramal Healthcare Limited was later merged with the group’s flagship pharma company Nicholas Piramal India Ltd. For the past 40 years, Nicholas Piramal India Limited’s vitamin and fine chemicals division has been manufacturing and selling the most important micro-nutrients and vitamin A. The plant at Thane have obtained the coveted ISO 9001 and ISO 14000 certificates and also the SQF 2000 and HACCP Certification and the Pithampur plant obtained ISO 14000 certificate from BVQI, making NPIL one of the first seven pharmaceutical companies in India to do so.
Orchid Pharma Limited Orchid Pharma Limited, formerly Orchid Chemicals & Pharmaceuticals Limited, is an India-based pharmaceutical company. The company is globally present across 70+ countries through alliances, joint ventures and partnerships with globally reputed majors. The Company is involved in the development, manufacture and marketing of various bulk actives, formulations and nutraceuticals. It offers active pharmaceutical ingredients (API), including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Established in 1992 as an export-oriented unit (EOU), Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. The company today rank among the top 15 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products
Paras Pharmaceuticals Limited Paras Pharmaceuticals Limited is one of the India’s leading FMCG company with household brands in the healthcare and personal care space. The company has over four decades of experience and a series of successful brand launches. The innovative nature of our products have gained wide acceptance beyond national boundaries.
Paras Pharmaceuticals is known for developing new categories and is widely respected for its category creation ability. As a result, the company has one super brand in pain management and we are market leaders in at least two other healthcare categories. As a corporate the company believes in providing innovative solutions to everyday health and personal care problems and has an entrepreneurial culture to build categories and brands.
Pfizer Limited Pfizer Limited is an India-based pharmaceutical company that has a portfolio of approximately 140 products across over 15 therapeutic areas. The company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products.
The company offers a range of products for anti-allergic, anti-diabetic, antihistamine, anti-infectives, cardiovascular, dermatology, erectile dysfunction, gastrointestinal (GI), multivitamins among others.
The company has its own manufacturing facility at Thane and Goa. It has various independent contract/ third party manufacturers based across the country. The company sells its products through independent distributors primarily in India. Pfizer has won the Golden Peacock Innovative Product for Magnex.
Piramal Healthcare Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries forayed into the health care space in 1988.
Piramal Healthcare has its manufacturing bases across India, UK, Scotland, USA and Canada through subsidiaries. At present it is the third largest player in the global Inhalation Anesthesia (IA) market, and the only company in the world with a complete product portfolio of inhalation anesthetics drugs.
Piramal Healthcare have partnered with the largest and most reputed organizations in the global pharmaceuticals industry to expand our product offering and deliver the best innovations to our customers.
Piramal Healthcare is made up of the following seven key business divisions: Pharma solutions, critical care, consumer products, imaging and phyto-medicines.
Panacea Biotec Limited Panacea Biotec Limited is a health management company, set up in 1984, with a commitment to make novel and innovative medicines affordable to the masses a dream of healthy India, and got listed in 1995 as Panacea Biotec Ltd.
The company’s principal business activity is the 
manufacture of allopathic pharmaceuticals preparations. Its segments include vaccines, formulations, research and development. The company’s product portfolio includes prescription products in therapeutic areas, such as oncology, and nephrology and transplant management.
Panacea Biotec is the largest vaccine manufacturing company in India and is well acknowledged by the UN Health Agencies in partnering the Polio eradication initiative with supplies of millions of doses of WHO Pre-qualified Polio vaccine. Panacea Biotec is the first company in to have developed fully liquid Pentavalent vaccine.
Sanofi India Limited Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions since 1956.
The company operates through three segments: pharmaceuticals, human vaccines (Vaccines) and animal health.
Sanofi India Limited was incorporated under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited and Hoechst Marion Roussel Limited. The shares of Sanofi India Limited are quoted on the Bombay Stock Exchange and the National Stock Exchange.
It also operates in the other segment, which includes the effects of retained commitments in respect of divested activities.
SeQuent Scientific Limited SeQuent Scientific Limited is a holding company, whose segments include pharmaceuticals, specialty chemicals and analytical services. It focuses on products for livestock, poultry and companion animals. It also offers laboratory and technical support services. On the human health front, the company serves the female healthcare with focus on steroids and hormones. Ever since inception in 2002 SeQuent has emerged as an integrated pharmaceutical company with a global footprint, operating in the domains of animal health (API and formulation) and human health (API). The company is equipped to cater to the domestic and global demands with cutting- edge R&D, highly flexible manufacturing capabilities and a competitive supply-chain network.
Shasun Pharmaceuticals Limited Shasun Pharmaceuticals Limited is an integrated, leading global supplier of development and manufacturing services for intermediates, API (active pharmaceutical ingredients) and formulations to the pharmaceutical industry. Shasun Pharmaceuticals Limited (Formerly known as Shasun Chemicals and Drugs Ltd.) was incorporated in 1976 and is headquartered in Chennai.
The company is a manufacturer and supplier of Ibuprofen and Ibuprofen derivatives. It offers a range of products in the areas of pain management, anti ulcerants and central nervous system (CNS). It offers services from the discovery stage to commercial manufacture and formulations. It offers technology services, which include chiral technologies and fluorination. It offers APIs for pain management and musculoskeletal, cardiovascular, antiinfective, gastrointestinal and cough suppressants, among others.
Strides Shasun Limited Strides Shasun Limited (Formerly Strides Arcolab Limited), incorporated in 1990, manufactures pharmaceutical dosage forms in branded as well generic categories. The dosages are manufactured in form of tablets, capsules, soft gelatin capsules, parenterals and semi–solids.
The company manufactures soft gels and steriles. It has 13 manufacturing facilities located across the world –– in India, Singapore, Brazil, Mexico, Poland, Italy.These facilities have received approval from various regulatory authorities namely MHHRA, TGA, MCC, ANVISA. The company’s Bangalore plant is pre–qualified by WHO to manufacture of HIV/ AIDS and anti–TB drugs.
The company is among the top 5 soft gelatin capsule manufacturers in world. It has partnered with major pharmaceutical companies located in Australia, South Africa, Europe, and USA. The company has a joint venture with Akorn –– Akorn–Strides, LLC –– to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets.
Shilpa Medicare Limited Shilpa Medicare Limited was incorporated in 1987 at Raichur, Karnataka. The commercial production in the SML was started in November 1989. It is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The company’s segments include bulk drug/intermediates and energy. It deals with APIs, intermediates, formulations, new drug delivery systems, peptides/biotech products and specialty chemicals.
Shilpa Medicare’s facilities have received key regulatory approvals for its facilities as well as for the products from EDQM, UK-MHRA, TGA, USFDA, PMDA and KFDA.
Suven Life Sciences Suven Life Sciences was promoted by Venkat Jasti couple, in 1989, as a Private Limited Company. Later, it was converted into a public limited company in January 1995. Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.
The company has six internally discovered therapeutic drug candidates currently, in pre–clinical stage of development targeting conditions such as ADHD, dementia, depression, Huntington’s disease. Parkinson’s disease and obesity are in addition to developmental candidate SUVN–502 for Alzheimer’s disease and Schizophrenia.
Shares are listed at BSE, NSE, and Hyderabad Stock Exchange (HSE). It has a state of the art R&D center recognized by Department of Scientific & Industrial Research (DSIR), Ministry of Science and Technology.
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited’s business segments include US business, Indian branded generics business, emerging markets, global consumer healthcare business and active pharmaceutical ingredients (API). Its rest of world segment includes western Europe, Canada, Australia, New Zealand and other markets.
The company offers its products to therapy areas, such as cardiology, neuro-psychiatry, gastroenterology, anti-infective, diabetology and dermatology. Its products include AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its manufacturing units are in India, the United States and Brazil, among others.
It acquired Ranbaxy in 2014 and this makes Sun pharma the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest speciality generic company globally.
Torrent Pharmaceuticals Limited Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products. The company operates in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective, anti-diabetics and pain management segments. It offers products in various categories, including tablets, capsule and parenteral. Its geographical segments include India and abroad.
It has three world-class manufacturing facilities at Indrad (Gujarat), Baddi (Himachal Pradesh) and Sikkim. The facilities are approved by USFDA, WHO, MHRA, TGA and other global regulatory bodies. Torrent Pharma is the sole manufacturer of Insulin Formulations for Novo Nordisk in India since the early ‘90s and has also set up a dedicated formulation and packaging facility for Insulin. Recently, Torrent Pharma acquired the branded domestic formulations business of Elder Pharmaceuticals in India and Nepal. Torrent Pharma has a strong international presence spanning over 40 countries with over 1200 product registrations.
Unichem Laboratories Limited Unichem Laboratories Limited manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has various pharma products for addressing therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management. Its brands include Losar, TG Tor, Olsar, Tolol and Trika.
Promoted by a pioneer of the Indian pharmaceuticals business, Amrut Mody, Unichem Laboratories has grown to become one of India’s most respected pharmaceutical companies. It is committed to delivering better health through superior products.
By combining strategic research and in-depth industry knowledge, Unichem aims to transform itself into a global pharmaceutical drug company with an increasing focus on cutting- edge research and developed markets.
Wockhardt Limited Wockhardt Limited is a pharmaceutical and biotechnology company. Wockhardt is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. The company’s businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. It has approximately three research centers globally. Wockhardt is a true Indian multi-national company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has three research centres and 12 manufacturing plants
USV Limited USV Limited is a 55 year old leading healthcare company thatbegan as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. The company’s products includes active pharmaceutical ingredients (APIs), fixed dosages formulations (FDF), peptides, biosimilars and
injectables. These are manufactured in the company’s CGMP compliant plants in India. USV Limited markets its products globally to 75 countries. In India, the company is recognised for its leadership in the oral anti-diabetic market. USV has a significant presence in the areas of vitamins, minerals, nutrients, dermatology, gastroenterology and CNS.
Zydus Cadila Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. Zydus Cadila, with a core competence in the field of healthcare provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products.
The group has launched Exemptia, the world’s first biosimilar for adalimumab, the largest selling therapy worldwide for inflammatory arthritis. Zydus is also the only Indian pharma company to launch its own patented NCE – Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia.
The group was incorporated in 1952 by Late Mr. Ramanbhai B. Patel, a first-generation entrepreneur and one of the stalwarts of the Indian pharmaceutical industry. In 1995, the group restructured its operations and Cadila Healthcare came into being under the aegis of the Zydus group. Zydus Cadila, today, is spearheaded by Pankaj R. Patel, the Chairman and Managing Director of the group.
